Severity of malignancy, preoperative serum albumin concentration, intraoperative blood loss and duration of operation, among other factors, predict postoperative pneumonia (POP) development following major oral cancer (OC) surgery, a recent study has found.
Current tobacco smoke exposure (TSE) is not related to airflow obstruction in school-aged children, a study suggests. On the other hand, an association exists between prenatal TSE and airflow obstruction in asthmatic children.
In Korean male tuberculosis (TB) patients, low bone mineral density and sarcopenia are prevalent, a recent study has shown. Moreover, TB history and TB scars on chest X-rays are independent risk factors for osteoporosis.
Metformin may improve survival during tuberculosis (TB) treatment in patients with diabetes mellitus—a condition which particularly carries an increased risk of adverse TB treatment outcomes, a study has found.
In patients with underlying heart failure (HF) or chronic obstructive pulmonary disease (COPD), concurrent episodes of community-acquired pneumonia increase the risk of disease exacerbations, such as short-term cardiac complications and respiratory failure, a recent study has shown.
Use of definitive treatment for stage I nonsmall cell lung cancer (NSCLC), whether surgery or radiation therapy (RT), has increased between 2000 and 2010 and has resulted in improvements in survival, a new study suggests.
The use of noninvasive ventilation during cycle exercise training in patients with chronic respiratory failure (CRF) leads to an improvement in endurance time but not in 6-min walking distance, a study has shown.
Airway inflammation, thought to explain the difference in asthma severity, is associated with the microbiota composition in the lower airway, a recent study suggests. Moreover, inhaled corticosteroids appear to alter the inflammatory response.
Middle East Respiratory Syndrome (MERS) patients have more severe illness and a higher mortality rate than non-MERS severe acute respiratory infection (SARI) patients, according to a study presented at the recent American Thoracic Society (ATS) International Conference 2016 held in San Francisco, California, US.
Fixed-dose combinations of long-acting β2-agonist (LABA) and muscarinic antagonist (LAMA) offered superior efficacy and comparable safety to LAMA or LABA/inhaled corticosteroid (ICS), the two most commonly prescribed first-line treatments for stable moderate-to-very-severe chronic obstructive pulmonary disease (COPD), according to a meta-analysis.
New drug applications approved by US FDA as of 16 - 30 Apr 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.